Please login to the form below

Not currently logged in
Email:
Password:

Pharming

This page shows the latest Pharming news and features for those working in and with pharma, biotech and healthcare.

EMA starts rapid review of Shire’s HAE antibody

EMA starts rapid review of Shire’s HAE antibody

Other approved treatments for HAE include CSL Behring’s Berinert and Pharming’s Ruconest.

Latest news

  • Opdivo backed for two new uses by CHMP Opdivo backed for two new uses by CHMP

    The CHMP also recommended extensions of indications for Boehringer Ingelheim's Giotrif (afatinib), Abbvie's Humira (adalimumab), Pharming's Ruconest (conestat alfa), Takeda's TachoSil (human thrombin/human fibrinogen) and

  • FDA approves drug for rare swelling diseases FDA approves drug for rare swelling diseases

    Salix and Pharming’s Ruconest is made from the milk of genetically-modified rabbits. ... Ruconest is developed in partnership by Salix Pharmaceutical and Pharming and is intended as a protein replacement in people with hereditary angioedema.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch August 2016 Deal Watch August 2016

    Finally it was interesting to see that Pharming has recovered from Valeant the North American rights to its product Ruconest. ... Pharming did well to get the rights back especially as it resulted in Valeant having to make a $199m write down of its

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics